The evolution of TheraSphere data since 1999
With over 100,000 patient treatments globally, TheraSphere research spans the BCLC guidelines from palliative to curative intent. Thanks to the work of Interventional Radiologists, since 1999 TheraSphere data has evolved dosimetry and delivery technique, demonstrating the power of selective, ablative, and personalized treatment, delivering durable patient outcomes and reproducible results. TheraSphere built the HCC Y-90 market and continues to trailblaze to advance patient care.